0
Prioritizing Medical Countermeasures for National Security Act of 2023
12/15/2023, 4:07 PM
Summary of Bill S 1122
The bill outlines several key provisions, including the establishment of a National Medical Countermeasure Prioritization Task Force. This task force would be responsible for identifying and prioritizing medical countermeasures that are critical to national security. Additionally, the bill calls for the creation of a National Medical Countermeasure Stockpile, which would ensure that essential medical supplies are readily available in the event of a national emergency.
Furthermore, the bill emphasizes the importance of collaboration between government agencies, private sector partners, and international organizations in order to effectively respond to public health threats. It also highlights the need for increased funding and resources to support the development and distribution of medical countermeasures. Overall, Bill 118 s 1122 aims to strengthen the nation's ability to respond to biological threats and other public health emergencies by prioritizing the development and distribution of medical countermeasures. If passed, this legislation could have a significant impact on national security and public health preparedness.
Congressional Summary of S 1122
Prioritizing Medical Countermeasures for National Security Act of 2023
This bill requires the Administration for Strategic Preparedness and Response (ASPR) to establish a list of categories of drugs that may be necessary to address a public health emergency or threat to the Armed Forces in order to facilitate the development of such drugs.
Specifically, ASPR must list categories and classes of drugs that may be necessary to prevent or treat diseases or conditions that are caused by chemical, biological, radiological, or nuclear agents and that have the potential to cause a public health emergency that threatens national security, or that may pose a threat to the Armed Forces. ASPR must share the list with interested parties to incentivize development and speed review of relevant drug applications.
The Government Accountability Office must report on the bill's effectiveness in encouraging the development of necessary medical countermeasures.
